Long-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome

por Fadda, Valeria, Maratea, Dario
Publicado 2016

Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Dia...

por Messori, Andrea, Fadda, Valeria, Maratea, Dario, Trippoli, Sabrina, Marinai, Claudio
Publicado 2014

New Oral Anticoagulants in Acute Coronary Syndrome: Is There Any Advantage Over Existing Treatments?

por Messori, Andrea, Fadda, Valeria, Gatto, Roberta, Maratea, Dario, Trippoli, Sabrina
Publicado 2014

Biological drugs for inducing remission in patients with Crohn's disease: determining statistical equivalence according to evidence-based methods

por Messori, Andrea, Fadda, Valeria, Maratea, Dario, Trippoli, Sabrina, Marinai, Claudio
Publicado 2015

Subcutaneous Biological Treatments for Moderate to Severe Psoriasis: Interpreting Safety Data by Network Meta-Analysis

por Messori, Andrea, Trippoli, Sabrina, Fadda, Valeria, Maratea, Dario, Marinai, Claudio
Publicado 2015

The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective

por Maratea, Dario, Bettio, Monica, Corti, Maria Grazia, Montini, Giovanni, Venturini, Francesca
Publicado 2016

GPR35 Activation Reduces Ca(2+) Transients and Contributes to the Kynurenic Acid-Dependent Reduction of Synaptic Activity at CA3-CA1 Synapses

por Berlinguer-Palmini, Rolando, Masi, Alessio, Narducci, Roberto, Cavone, Leonardo, Maratea, Dario, Cozzi, Andrea, Sili, Maria, Moroni, Flavio, Mannaioni, Guido
Publicado 2013

Correction: GPR35 Activation Reduces Ca(2+) Transients and Contributes to the Kynurenic Acid-Dependent Reduction of Synaptic Activity at CA3-CA1 Synapses

por Berlinguer-Palmini, Rolando, Masi, Alessio, Narducci, Roberto, Cavone, Leonardo, Maratea, Dario, Cozzi, Andrea, Sili, Maria, Moroni, Flavio, Mannaioni, Guido
Publicado 2014